Press Room

Share

New American Cancer Society Finds Increasing Access to Medicaid Saves Lives from Cancer

May 20, 2021

A new study from the American Cancer Society released by the American Society of Clinical Oncology (ASCO) shows the lifesaving impact increasing access to Medicaid has on cancer survivorship. The study finds that patients with cancer living in states with lower Medicaid income eligibility limits had worse long-term survival rates. ACS CAN has long advocated for states to increase access to Medicaid and continues to work with lawmakers in the 12 remaining states that have not yet done so to take this critical step to ensure more individuals have access to Medicaid programs. Increasing access to more adults with lower incomes promotes earlier cancer detection, fewer deaths and improved outcomes for patients.

ASCO’s media statement on Association of state Medicaid income eligibility limits and long-term survival after cancer diagnosis in the United States

More Press Releases AboutAccess to Health Insurance, Increased Access to Medicaid, Access to Health Care, Reducing Health Disparities

Media Contacts

Emily Burr
Director, Media Advocacy
Washington, D.C.
[email protected]
202.585.3296
Alissa Crispino
Vice President, Media Advocacy & Communications
Washington, D.C.
[email protected]
202.661.5772

Related Press Releases

March 26, 2024

Hawaii Cancer Survivors, Patients Rally at State Capitol in Effort to Reduce Health Disparities

 American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Hawaii met with their legislators at the Hawaii State Capitol Thursday to urge them to support HB1301. If enacted, the policy would enable funding for a multiethnic cohort study by the University of Hawaii Cancer Center, the only National Cancer Institute-designated cancer center in the Hawaii Pacific region.

Read More
February 22, 2024

New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes

A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and creating disparities that impact diverse populations.

 

Read more
February 2, 2024

Non-Medical Costs Associated with Clinical Trials Continue to be Barrier to Diverse Participation

WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) was joined by 20 other organizations in proposing the Health and Human Services Office of Inspector General adopt a new regulatory safe harbor from the Anti-kickback Statute that would allow cli

Read more